Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03305562 · ClinicalTrials.gov registry record
Pediatric Hypertension Registry (PHREG)
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 179
- Enrollment target
NCT03305562 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 179 participants.
The verdict
NCT03305562 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 179 participants
- Enrollment target
Study Summary
Pediatric hypertension is increasingly common and is a precursor for adult cardiovascular and renal disease. But even during childhood, hypertension is associated with significant morbidity, including cognitive impairment and organ damage. However, the cause of pediatric hypertension, the response to treatment, and the mechanisms behind organ damage are incompletely understood. Due to these limitations, there are no first-line medications, and treatment is often inadequate. An improved comprehension of the course of pediatric hypertension could enhance clinical care. The goal of this proposal is to create a registry of patients with hypertension to better enable research into this important disease. This patient registry will enhance the investigators ability to quickly collect and analyze data for research studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2017-09-20 |
| Est. Completion | 2021-06-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03305562
The ClinicalTrials.gov registry entry for NCT03305562 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03305562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03305562 about?
NCT03305562 is a clinical study titled "Pediatric Hypertension Registry (PHREG)". Pediatric hypertension is increasingly common and is a precursor for adult cardiovascular and renal disease. But even during childhood, hypertension is associated with significant morbidity, including cognitive impairment and organ damage. However, the cause of pediatric hypertension, the response t...
What is the current status of trial NCT03305562?
This trial is currently terminated. The enrollment target is 179 participants. The study started on 2017-09-20. Estimated completion is 2021-06-22.
Who is sponsoring clinical trial NCT03305562?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.